LUCA Science
4 known investors
Find your way into LUCA Science
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction. The company works in the biopharmaceutical field, building a platform based on its proprietary iMIT mitochondria technology.
Investors · 4
Funding
SEC filings, press & company announcements$30M disclosed across 1 round · 2022
- $30MSeries BJun 2022 · 4 sources
4BIO Capital (lead), DCI Partners (lead), Fast Track Initiative (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does LUCA Science do?
- LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction. The company works in the biopharmaceutical field, building a platform based on its proprietary iMIT mitochondria technology.
- Who are LUCA Science's investors?
- LUCA Science's investors include Fast Track Initiative, Remiges Ventures, Inc., 4BIO Capital, DCI Partners Co. Ltd..
- How much funding has LUCA Science raised?
- LUCA Science has disclosed $30M raised across 1 round.